科源制药(301281.SZ):拟推2025年限制性股票激励计划

Core Viewpoint - Koyuan Pharmaceutical (301281.SZ) announced a restricted stock incentive plan for 2025, aiming to grant a total of 3 million shares, which represents approximately 2.77% of the company's total share capital of 108.29 million shares at the time of the announcement [1] Summary by Category Incentive Plan Details - The incentive plan involves granting restricted stocks to a total of 35 recipients [1] - The initial grant price for the restricted stocks is set at 14.71 yuan per share [1]